Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.60 USD
-0.08 (-2.99%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $2.68 +0.08 (3.08%) 7:00 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 14.29% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.14 |
Next Year | -0.76 |
EPS (TTM) | -0.82 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.32 | -1.14 | -0.76 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.31 | -0.32 | -1.14 | -0.76 |
High Estimate | -0.31 | -0.32 | -1.14 | -0.76 |
Low Estimate | -0.31 | -0.32 | -1.14 | -0.76 |
Year ago EPS | -0.19 | -0.21 | -0.91 | -1.14 |
Year over Year Growth Est. | -63.16% | -52.38% | -25.27% | 33.33% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.31 | -0.32 | -1.14 | -0.76 |
7 Days Ago | -0.31 | -0.32 | -1.14 | -0.76 |
30 Days Ago | -0.31 | -0.32 | -1.14 | -0.76 |
60 Days Ago | -0.31 | -0.32 | -1.14 | -0.76 |
90 Days Ago | NA | NA | -1.29 | -0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.32 | -1.14 | -0.76 |
Zacks Consensus Estimate | -0.31 | -0.32 | -1.14 | -0.76 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.18 | -0.21 | -0.19 | NA |
Estimate | -0.28 | -0.35 | -0.30 | -0.29 | NA |
Difference | 0.04 | 0.17 | 0.09 | 0.10 | 0.10 |
Surprise | 14.29% | 48.57% | 30.00% | 34.48% | 31.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more